Experimental herpes drug more effective than standard treatm
An experimental drug for genital herpes that showed promising results in a small, early-phase clinical trial has done so again in a second trial, this time outperforming the current treatment in a head-to-head comparison, according to a study published Tuesday in JAMA.

“We showed that the new drug, pritelivir, which is still in early development, reduced the rate of viral shedding more than the standard, valacyclovir,” said Dr. Anna Wald, a University of Washington and Fred Hutchinson Cancer Research Center researcher and lead author of the new study. In fact, Wald added, “I was surprised at how much more effective pritelivir was.”....

http://www.fredhutch.org/en/news/center-news/2016/12/experimental-herpes-drug-pritelivir-more-effective-than-standard-treatment.html
Like
Comment
Share